|
|
|
|
| LEADER |
03778nam a22003495i 4500 |
| 001 |
000279509 |
| 005 |
20220124100346.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2002 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780306468179
|
| 024 |
7 |
|
|a 10.1007/b113267
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Cancer Gene Therapy :
|b Past Achievements and Future Challenges /
|c edited by Nagy Habib.
|
| 250 |
|
|
|a 1st ed. 2002.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2002.
|
| 300 |
|
|
|a XVI, 496 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 465
|
| 505 |
0 |
|
|a The Clinical Problem -- Management Problems in Oncology -- Vectors -- Adenoviral Vectors -- Retrovirus Vectors -- Targetable Gene Delivery Vectors -- Human ?-fetoprotein Transcriptional Regulatory Sequences -- Tumor-Targeted Salmonella -- Mutant Adenoviruses Selectively Replication-Competent in Tumor Cells -- Polyoma and Papilloma Virus Vectors For Cancer Gene Therapy -- Cochleates -- The Use Of Skeletal Muscle To Express Genes For The Treatment Of Cancer -- Cell Cycle Control -- Adhesion Molecules in Cancer Biology -- Cell Cycle Control -- Apoptosis -- Killer/DR5, A Novel DNA-Damage Inducible Death Receptor Gene, Links the p53-Tumor Suppressor to Caspase Activation and Apoptotic Death -- Apoptin® -- Adenovirus-Mediated Herpes Simplex Thymidine Kinase Gene Therapy For Brain Tumors -- Development of Clinical Trial of E1A Gene Therapy Targeting HER-2/neu-overexpressing Breast and Ovarian Cancer -- Tumout Suppressor Genes -- Pre-clinical Studies with Tumor Suppressor Genes -- Gene Therapy for Liver Tumours -- Adenovirus-mediated Transfer of a p53 Gene in Ovarian Cancer -- Other Systems -- Eliciting Hyperacute Rejection as a Tumor Killing Strategy -- Innate Immune Therapy For Cancer -- Mda-7, A Novel Melanoma Differentiation Associated Gene with Promise for Cancer Gene Therapy -- Antisense and Ribozymes -- Antisense IGF and Antisense IGF-IR Therapy of Malignancy -- Sensitization of Tumors to Chemotherapy Through Gene Therapy -- Design and Testing of Ribozymes for Cancer Gene Therapy -- Ribozymes -- The Approach of Triple Helix Formation in Control of Gene Expression and The Treatment of Tumors Expressing IGF-I -- Immuno-Modulation -- Dendritic Cell-based Immunization for Cancer Therapy -- Hybrid Cell Vaccination for Cancer Immunotherapy -- Modulation of the Immune Response Through 4-1BB -- Heat Shock Proteins in Cancer Therapy -- Bi-Specific Antibodies in Cancer Therapy -- B7.1 and Cytokines -- Intralesional Vaccinia/GM-CSF Recombinant Virus in the Treatment of Metastatic Melanoma -- Suicidal Genes -- Approaches to Gene-Directed Enzyme Prodrug Therapy (GDEPT) -- Suicide Gene Therapy -- Adenoviruses as Gene Delivery Vectors -- Angiogenesis Control -- Evaluation of an Inhibitor of DNA Methylation, 5-aza-2?-Deoxycytidine, for The Treatment of Lung Cancer and the Future Role of Gene Therapy -- Vascular Endothelial Growth Factor as a Target for Cancer Gene Therapy -- Adeno-Associated Virus and Other Potential Vectors for Angiostatin and Endostatin Gene Therapy -- Matrix Metallo Proteinase -- Potential Applications of Tissue Inhibitor of Metalloproteinase (TIMP) Overexpression For Cancer Gene Therapy.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Animal anatomy.
|
| 650 |
1 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Animal Anatomy / Morphology / Histology.
|
| 700 |
1 |
|
|a Habib, Nagy.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|